Cerebral ischemic stroke: Is gender important?

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 9, 2013, Pages 1355-1361

  Gibson, Claire L ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

acute stroke; brain ischemia; gender; neuroprotection; steroids

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR; ANTITHROMBOCYTIC AGENT; APOPTOSIS INDUCING FACTOR; CASPASE 3; CYTOCHROME C; CYTOCHROME P450; ESTROGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MINOCYCLINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NITRIC OXIDE SYNTHASE; PROGESTERONE; SEX HORMONE; TISSUE PLASMINOGEN ACTIVATOR;

APHASIA; ATAXIA; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; CORONARY ARTERY DISEASE; DEPRESSION; DIPLOPIA; DISABILITY; DISORIENTATION; DIZZINESS; DYSARTHRIA; ECHOCARDIOGRAPHY; ENDARTERECTOMY; FAMILY HISTORY; FIBRINOLYTIC THERAPY; HEADACHE; HELP SEEKING BEHAVIOR; HEMIPARESIS; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; MENTAL DISEASE; MENTAL HEALTH; META ANALYSIS (TOPIC); MORBIDITY; MORTALITY; MUSCLE WEAKNESS; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PAIN; PARESTHESIA; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEX DIFFERENCE; SMOKING; TREATMENT RESPONSE; VERTIGO; VISUAL DISORDER;

ANIMALS; BRAIN ISCHEMIA; FEMALE; HUMANS; MALE; SEX CHARACTERISTICS; STROKE;

EID: 84883742696     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2013.102     Document Type: Review

References (116)

1. Rojas JI, Zurru MC, Romano M, Patrucco L, Cristiano E. Acute ischemic stroke and transient ischemic attack in the very old-risk factor profile and stroke subtype between patients older than 80 years and patients aged less than 80 years. Eur J Neurol 2007; 14: 895-899. (Pubitemid 47106773)
2. Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB et al. The lifetime risk of stroke: estimates from the Framingham Study. Stroke 2006; 37: 345-350. (Pubitemid 43731985)
3. Reeves MJ, Bushnell CD, Howard G, Gargano JW, Duncan PW, Lynch G et al. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol 2008; 7: 915-926.
4. Di Carlo A, Lamassa M, Baldereschi M, Pracucci G, Basile AM, Wolfe CD et al. Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry. Stroke 2003; 34: 1114-1119. (Pubitemid 36547498)
5. Kapral MK, Fang J, Hill MD, Silver F, Richards J, Jaigobin C et al. Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network. Stroke 2005; 36: 809-814.
6. Simpson CR, Wilson C, Hannaford PC, Williams D. Evidence for age and sex differences in the secondary prevention of stroke in Scottish primary care. Stroke 2005; 36: 1771-1775. (Pubitemid 41098777)
7. Niewada M, Kobayashi A, Sandercock PA, Kaminski B, Czlonkowska A. Influence of gender on baseline features and clinical outcomes among 17,370 patients with confirmed ischaemic stroke in the International Stroke Trial. Neuroepidemiology 2005; 24: 453-460.
8. Gargano JW, Wehner S, Reeves MJ. Delays among patients with acute stroke. do presenting symptoms explain sex differences in emergency department? Stroke 2009; 40: 1114-1120.
9. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117: e25-146.
10. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991; 121: 293-298.
11. Fullerton HJ, Wu YW, Zhao S, Johnston SC. Risk of stroke in children. Neurol 2003; 61: 189-194.
12. Golomb MR, Fullerton HJ, Nowak-Gottl U, Deveber G. Male predominance in childhood ischemic stroke: findings from the international pediatric stroke study. Stroke 2009; 40: 52-57.
13. Wang Z, Li J, Wang C, Yao X, Zhao X, Zhao X et al. Gender differences in 1-year clinical characteristics and outcomes after stroke: results from the China national stroke registry. PLoS ONE 2013; 8: e56459.
14. Fukuda M, Kanda T, Kamide N, Akutsu T, Sakai F. Gender differences in long-term functional outcome after first-ever ischemic stroke. Inter Med 2009; 48: 967-973.
15. Elijovich L, Chong JY. Current and future use of intravenous thrombolysis for acute ischaemic stroke. Curr Atheroscler Rep 2010; 12: 316-321.
16. Allen CL, Bayraktutan U. Risk factors for ischaemic stroke. Int J Stroke 2008; 3: 105-116. (Pubitemid 351566844)
17. Hankey GJ. Smoking and risk of stroke. J Cardiovasc Risk 1999; 6: 207-211. (Pubitemid 29421880)
18. Kirshner HS. Differentiating ischemic stroke subtypes: risk factors and secondary prevention. J Neurol Sci 2009; 279: 1-8.
19. Whisnant JP. Effectiveness versus efficacy of treatment of hypertension for stroke prevention. Neurology 1996; 46: 301-307. (Pubitemid 26081304)
20. Arboix A, Oliveres M, Garciá-Eroles L, Maragall C, Massons J, Targa C. Acute cerebrovascular disease in women. Eur Neurol 2001; 45: 199-205. (Pubitemid 32521036)
21. Palm F, Urbanek C, Olf J, Buggle F, Kleeman T, Hennerici MG et al. Etiology, risk factors and sex differences in ischemic stroke in the Ludwigshafen stroke study, a population-based stroke registry. Cerebrovasc Dis 2012; 33: 69-75.
22. Roquer J, Campello AR, Gomis M. Sex differences in first-ever acute stroke. Stroke 2003; 34: 1581-1585. (Pubitemid 36842605)
23. Fö rster A, Gass A, Kern R, Wolf ME, Ottomeyer C, Zohsel K et al. Gender differences in acute ischemic stroke. Etiology, stroke patterns and response to thrombolysis. Stroke 2009; 40: 2428-2432.
24. Touzé E, Rothwell PM. Sex differences in heritability of ischemic stroke. A systematic review and meta-analysis. Stroke 2008; 39: 16-23.
25. Heim LJ, Brunsell SC. Heart disease in women. Prim Care 2000; 27: 741-746.
26. Lisabeth LD, Brown DL, Hughes R, Majersik JJ, Morgenstern LB. Acute stroke symptoms, comparing women and men. Stroke 2009; 40: 2031-2036.
27. Stuart-Shor E, Wellenius GA, Dellolacono DM, Mittleman MA. Gender differences in presenting and prodromal stroke symptoms. Stroke 2009; 40: 1121-1126.
28. Labiche L, Chan W, Saldin K, Morgenstern L. Sex and acute stroke presentation. Ann Emerg Med 2002; 40: 453-460. (Pubitemid 35231567)
29. Jerath NU, Reddy C, Freeman D, Jerath AU, Brown RD. Gender differences in presenting signs and symptoms of acute ischemic stroke: a population-based study. Gend Med 2011; 8: 312-319.
30. Mandelzweig L, Goldbourt U, Bokyo V, Tanne D. Perceptual, social, and behavioural factors associated with delays in seeking medical care in patient with symptoms of acute stroke. Stroke 2006; 37: 1248-1253. (Pubitemid 43731871)
31. Kleindorfer DO, Miller R, Moomaw CJ, Alwell K, Broderick JP, Khoury J et al. Designing a message for public education regarding stroke: does FAST capture enough stroke? Stroke 2007; 38: 2864-2868. (Pubitemid 47494033)
32. Appelros P, Stegmayr B, Terent A. Sex differences in stroke epidemiology: a systematic review. Stroke 2009; 40: 1082-1090.
33. Park SJ, Shin SD, Ro YS, Son KJ, Oh J. Gender differences in emergency stroke care and hospital outcome in acute ischemic stroke: a multicenter observational study. Am J Emerg Med 2013; 31: 178-184.
34. Silva GS, Lima FO, Camargo ECS, Smith WS, Lev MH, Harris GJ et al. Gender differences in outcomes after ischemic stroke: role of ischemic lesions volume and intracranial large-artery occlusion. Cerebrovasc Dis 2010; 30: 470-475.
35. Glader EL, Stegmayr B, Norrving B, Terent A, Hulter-Asberg K, Wester PO et al. Sex differences in management and outcome after stroke: a Swedish national perspective. Stroke 2003; 34: 1970-1975. (Pubitemid 36944792)
36. Eriksson M, Asplund K, Glader EL, Norrving B, Stegmayr B, Terent A et al. Selfreported depression and use of antidepressants after stroke. Stroke 2004; 35: 936-941. (Pubitemid 38419806)
37. Glader EL, Stegmayr B, Asplund K. Poststroke fatigue: a 2-year follow-up study of stroke patients in Sweden. Stroke 2002; 33: 1327-1333. (Pubitemid 34517055)
38. Franzen-Dahlin A, Laska AC. Gender differences in quality of life after stroke and TIA: a cross-sectional survey of out-patients. J Clin Nurs 2012; 21: 2386-2391.
39. Gokkaya NK, Aras MD, Cakci A. Health-related quality of life of Turkish stroke survivors. Int J Rehabi Res 2005; 28: 229-235. (Pubitemid 44384133)
40. Sturm JW, Donnan GA, Dewey HM, Macdonell RA, Gilligan AK, Srikanth V et al. Quality of life after stroke: the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 2004; 35: 2340-2345. (Pubitemid 39311260)
41. Ramani S, Byrne-Logan S, Freund KM, Ash A, Yu W, Moskowitz MA. Gender differences in the treatment of cerebrovascular disease. J Am Geriatr Soc 2000; 48: 741-745. (Pubitemid 30457410)
42. Smith MA, Lisabeth LD, Brown DL, Morgenstern LB. Gender comparisons of diagnostic evaluation for ischemic stroke patients. Neurology 2005; 65: 855-858. (Pubitemid 41362129)
43. Gargano JW, Wehner S, Reeves M. Sex differences in acute stroke care in a statewide stroke registry. Stroke 2008; 39: 24-29.
44. Group SCotPHSR. Final report on the aspirin component of the ongoing physicians' health study. Steering committee of the Physicians' Health Study Research Group. N Engl J Med 1989; 321: 129-135.
45. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005; 352: 1293-1304.
46. Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA 2006; 295: 306-313.
47. Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D. Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment. Thromb Haemost 2009; 101: 938-942.
48. Hill MD, Kent DM, Hinchey J, Rowley H, Buchan AM, Wechsler LR et al. Sex-based differences in the effect of intra-arterial treatment of stroke: analysis of PROACT-2 study. Stroke 2006; 37: 2322-2325. (Pubitemid 44337177)
49. Kent DM, Buchan AM, Hill MD. The gender effect in stroke thrombolysis: of CASES, controls, and treatment-effect modification. Neurology 2008; 71: 1080-1083.
50. Shah SH, Liebeskind DS, Saver JL, Starkman S, Vinuela F, Duckwiler G et al. Influence of gender on outcomes after intra-arterial thrombolysis for acute ischemic stroke. Neurology 2006; 66: 1745-1746. (Pubitemid 43964636)
51. Jauch EC, Saver JL, Adams HP, Bruno A, Connors JJ, Demaerschalk BM et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44: 870-947.
52. Liu M, Dziennis S, Hurn PD, Alkayed NJ. Mechanisms of gender-linked brain injury. Restor Neurol Neurosci 2009; 27: 163-179.
53. Vagnerova K, Koerner IP, Hurn PD. Gender and the injured brain. Anesthesia and Analgesia 2008; 107: 201-204.
54. Heyer A, Hasselblatt M, von Ahsen N, Hafner H, Siren AL, Ehrenreich H. In vitro gender differences in neuronal survival on hypoxia in 17b-estradiol-mediated neuroprotection. J Cereb Blood Flow Metab 2005; 25: 317-321.
55. Li H, Pin S, Zeng Z, Wang MM, Andreasson KA, McCullough LD. Sex differences in cell death. Ann Neurol 2005; 58: 317-321. (Pubitemid 41098890)
56. Liu M, Hurn PD, Roselli CE, Alkayed NJ. Role of P450 aromatase in sex-specific astrocytic cell death. J Cereb Blood Flow Metab 2007; 27: 135-141. (Pubitemid 46006591)
57. Liu M, Oyarzabal EA, Yang R, Murphy SJ, Hurn PD. A novel method for assessing sex-specific and genotype-specific response to injury in astrocyte culture. J Neurosci Methods 2008; 171: 214-217.
58. McCullough LD, Zeng Z, Blizzard KK, Debchoudhury I, Hurn PD. Ischemic nitric oxide and ploy (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection. J Cereb Blood Flow Metab 2005; 25: 502-512.
59. Hagberg H, Wilson MA, Matsushita H, Zhu C, Lange M, Gustavsson M et al. PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury. J Neurochem 2004; 90: 1068-1075. (Pubitemid 39167340)
60. Liu F, Li Z, Li J, Siegel C, Yuan R, McCullough LD. Sex differences in caspase activation after stroke. Stroke 2009; 40: 1842-1848.
61. Renolleau S, Fau S, Goyenvalle C, Jloy LM, Chauvier D, Jacotot E et al. Specific caspase inhibitor Q-VD-OPh prevents neonatal stroke in P7 rat: a role for gender. J Neurochem 2007; 100: 1062-1071. (Pubitemid 46213929)
62. Yamori Y, Horie R, Handa H, Sato M, Fukase M. Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans. Stroke 1976; 7: 46-53.
63. Alkayed NJ, Harukuni I, Kimes AS, London ED, Traystman RJ, Hurn PD. Genderlinked brain injury in experimental stroke. Stroke 1998; 29: 159-166. (Pubitemid 28046959)
64. Hurn PD, Aardelt AA, Alkayed NJ, Crain BJ, Hu W, Kearney ML et al. In: Krieglsein J (eds) Pharmacology of Cerebral Ischemia. Medpharm Scientific Publishers: Stuttgart, 2002 P17-P24.
65. Wise PM, Dubal DB, Wilson ME, Rau SW, Bottner M, Rosewell KL. Estradiol is a neuroprotective factor in the adult and aging bran: understanding of mechanisms derived from in vivo and in vitro studies. Brain Res Brain Res Rev 2001; 37: 313-319. (Pubitemid 34020741)
66. Cheng J, Hurn PD. Sex shapes experimental ischemic brain injury. Steroids 2009; 75: 754-759.
67. Toung TJ, Hurn PD, Traystman RJ, Sieber FE. Estrogen decreases infarct size after temporary focal ischemia in a genetic model of type I diabetes mellitus. Stroke 2000; 31: 2701-2706.
68. Alkayed NJ, Murphy SJ, Traystman RJ, Hurn PD. Neuroprotective effect of female gonadal steroids in reproductively senescent female rats. Stroke 2000; 31: 161-168. (Pubitemid 30035770)
69. Gibson CL, Gray LJ, Murphy SP, Bath PMW. Estrogens and experimental ischemic stroke: a systematic review. J Cereb Blood Flow Metab 2006; 26: 1103-1113. (Pubitemid 44268172)
70. Gibson CL, Coomber B, Rathbone J. Is progesterone a candidate neuroprotective factor for treatment following ischemic stroke? Neuroscientist 2009; 15: 324-332.
71. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Makuch R, Horwitz RJ. A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 2001; 345: 1243-1249. (Pubitemid 34951488)
72. Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A et al. Effect of estrogen plus progestin on stroke in post-menopausal women-the Women's Health Initiative: a randomized trial. JAMA 2003; 289: 2673-2674.
73. Pathak EB, Sloan MA. Recent racial/ethnic disparities in stroke hospitalizations and outcomes for young adults in Florida, 2001-2006. Neuroepidemiology 2009; 32: 302-311.
74. Avendano M, Kawachi I, Van Lenthe F, Boshuizen HC, Mackenbach JP, Van den Bos GAM et al. Socioeconomic status and stroke incidence in the US elderly: the role of risk factors in the EPESE study. Stroke 2006; 37: 1368-1373. (Pubitemid 44305711)
75. Cox AM, McKevitt C, Rudd AG, Wolfe CDA. Socioeconomic status and stroke. Lancet Neurol 2006; 5: 181-188. (Pubitemid 43107853)
76. McFadden E, Luben R, Wareham N, Bingham S, Khaw K-T. Social class, risk factors, and stroke incidence in men and women. A prospective study in the European prospective investigation into cancer in Norfolk cohort. Stroke 2009; 40: 1070-1077.
77. Siegel C, Turtzo C, McCullough LD. Sex differences in cerebral ischemia: possible molecular mechanisms. J Neurosci Res 2010; 88: 2765-2774.
78. Mehta SL, Manhas N, Rahubir R. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Brain Res Rev 2007; 54: 34-66. (Pubitemid 46498164)
79. Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002; 297: 259-263. (Pubitemid 34761289)
80. Zhu C, Xu F, Wang X, Shibata M, Uchiyama Y, Blomgren K et al. Different apoptotic mechanisms are activated in male and female brains after neonatal hypoxia-ischemia. J Neurochem 2006; 96: 1016-1027.
81. Park EM, Cho S, Frys KA, Glickstein SB, Zhou P, Anrather J et al. Inducible nitric oxide synthase contributes to gender differences in ischemic brain injury. J Cereb Blood Flow Metab 2006; 26: 392-401.
82. Du L, Bayir H, Lai Y, Zhang X, Kockanek PM, Watkins SC et al. Innate genderbased proclivity in response to cytotoxicity and programmed cell death. J Biol Chem 2004; 279: 38563-38570. (Pubitemid 39296010)
83. Kitano H, Young JM, Cheng J, Wang L, Hurn PD, Murphy SJ. Gender-specific response to isoflurane preconditioning in focal cerebral ischemia. J Cereb Blood Flow Metab 2007; 27: 1377-1386. (Pubitemid 46985354)
84. Cordeau Jr P, Lalancette-Herbert M, Weng YC, Kriz J. Live imaging of neuroinflammation reveals sex and estrogen effects on astrocyte response to ischemic injury. Stroke 2008; 39: 935-942. (Pubitemid 351619580)
85. Sakata A, Mogi M, Iwanami J, Tsukada K, Min L-J, Fujita T et al. Sex-different effect of angiotensin II type 2 receptor on ischemic brain injury and cognitive function. Brain Res 2009; 1300: 14-23.
86. Zhang W, Iliff JJ, Campbell CJ, Wang RK, Hurn PD, Alkayed NJ. Role of soluble epoxide hydrolase in the sex-specific vascular response to cerebral ischemia. J Cereb Blood Flow Metab 2009; 29: 1475-1481.
87. Yuan M, Siegel C, Zeng Z, Li J, Liu F, McCullough LD. Sex differences in the response to activation of the poly (ADP-ribose) polymerase pathway after experimental stroke. Exp Neurol 2009; 217: 210-218.
88. Li J, McCullough LD. Sex differences in minocycline-induced neuroprotection after experimental stroke. J Cereb Blood Flow Metab 2009; 29: 670-674.
89. Shintani T, Klionsky DJ. Autophagy in health and disease: a double-edged sword. Science 2004; 306: 990-995. (Pubitemid 39482894)
90. Puyal J, Vaslin A, Mottier V, Clarke PG. Postischemic treatment of neonatal cerebral ischemia should target autophagy. Ann Neurol 2009; 66: 378-389.
91. Maggi A, Ciana P, Belcredito S, Vegeto E. Estrogens in the nervous system: mechanisms and nonreproductive functions. Annu Rev Physiol 2004; 66: 291-313. (Pubitemid 40626712)
92. Tian Y, Stamova B, Jickling GC, Liu D, Ander BP, Bushnell C et al. Effects of gender on gene expression in the blood of ischemic stroke patients. J Cereb Blood Flow Metab 2012; 32: 780-791.
93. Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA. Mortality in women with turner syndrome in Great Britain: a national cohort study. J Clin Endocrinol Metab 2008; 93: 4735-4742.
94. Turtzo LC, McCullough LD. Sex differences in stroke. Cerebrovasc Dis 2008; 26: 462-474.
95. Pantoni L, Garcia JH, Gutierrez JA. Cerebral white matter is highly vulnerable to ischemia. Stroke 1996; 27: 1641-1647. (Pubitemid 26295918)
96. Po C, Kalthoff D, Kim YB, Nelles M, Hoehn M. White matter reorganization and functional response after focal cerebral ischemia in the rat. PLOS One 2012; 7: e45629.
97. Clayden JD, Jentschke S, Munoz M, Cooper JM, Chadwick JM, Banks T et al. Normative development of white matter tracts: similarities and differences in relation to age, gender, and intelligence. Cereb Cortex 2012; 22: 1738-1747.
98. Yang S, Li C, Zhang W, Wang W, Tang Y. Sex differences in the white matter and myelinated nerve fibers of Long-Evans rats. Brain Res 2008; 1216: 16-23.
99. Cerghet M, Skoff RP, Bessert D, Zhang Z, Mullins C, Ghandour MS. Proliferation and death of oligodendrocytes and myelin proteins are differentially regulated in male and female rodents. J Neurosci 2006; 26: 1439-1447. (Pubitemid 43237014)
100. Liu R, Yang SH. Window of opportunity: estrogen as a treatment for ischemic stroke. Brain Res 2013; 1511: 83-90.
101. Suzuki S, Brown CM, Wise PM. Neuroprotective effects of estrogens following ischemic stroke. Front Neuroendocrinol 2009; 30: 201-211.
102. Henderson VW, Lobo RA. Hormone therapy and the risk of stroke: perspectives 10 years after the Women's Health Initiative trials. Climacteric 2012; 15: 229-234.
103. Gibson CL, Gray LJ, Bath PMW, Murphy SP. Progesterone for the treatment of experimental brain injury: a systematic review. Brain 2008; 131: 318-328. (Pubitemid 351197603)
104. Vannucci SJ, Hurn PD. Gender differences in pediatric stroke: is elevated testosterone a risk factor for boys? Ann Neurol 2009; 66: 713-714.
105. Jeppesen LL, Jorgensen HS, Nakayam H, Raaschou HO, Olsen TS, Winther K. Decreased serum testosterone in men with acute ischemic stroke. Arterioscler Thromb Vasc Biol 1996; 16: 749-754. (Pubitemid 26179363)
106. Yeap BB, Hyde Z, Almeida OP, Norman PE, Chubb SA, Jamrozik K et al. Lower testosterone levels predict incident stroke and transient ischemic attack in older men. J Clin Endocrinol Metab 2009; 94: 2353-2359.
107. Cheng J, Hu W, Toung TJ, Zhang Z, Parker SM, Roselli CE et al. Age-dependent effects of testosterone in experimental stroke. J Cereb Blood Flow Metab 2009; 29: 486-494.
108. Uchida M, Palmateer JM, Herson PS, DeVries AC, Cheng J, Hurn PD. Dosedependent effects of androgens on outcome after focal cerebral ischemia in adult male mice. J Cereb Blood Flow Metab 2009; 29: 1454-1462.
109. McCullough LD, Blizzard K, Simpson ER, Oz OK, Hurn PD. Aromatase cytochrome P450 and extragonadal estrogen play a role in ischemic neuroprotection. J Neurosci 2003; 23: 8701-8705. (Pubitemid 37176650)
110. Moulin T, Tatu L, Vuiller F, Berger E, ChvotD, Rumbach L. Role of a stroke data bank in evaluating cerebral infarction subtypes: patterns and outcomes of 1,776 consecutive patients from the Besancon stroke registry. Cerebrovasc Dis 2000; 10: 261-271. (Pubitemid 30430070)
111. Liu F, Yuan R, Benashski SE, McCullough LD. Changes in experimental stroke outcome across the life span. J Cereb Blood Flow Metab 2009; 29: 792-802.
112. Shapira S, Sapir M, Wengier A, Grauer E, Kadar T. Aging has a complex effect on a rat model of ischemic stroke. Brain Res 2002; 925: 148-158. (Pubitemid 34131631)
113. Wang RY, Wang PS, Yang YR. Effect of age in rats following middle cerebral artery occlusion. Gerontology 2003; 49: 27-32. (Pubitemid 35398577)
114. Lewis DK, Thomas KT, Selvamani A, Sohrabji F. Age-related severity of focal ischemia in female rats is associated with impaired astrocyte function. Neurobiol Aging 2012; 33: 1123.e1-1123.e16.
115. Mouton PR, Long JM, De-Liang L, Howard V, Jucker M, Calhoun ME et al. Age and gender effects on microglia and astrocyte numbers in brains of mice. Brain Res 2002; 956: 30-35. (Pubitemid 35335553)
116. Fisher M, Feuerstain G, Howells DW, Hurn PD, Kent TA, Savitz SI et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009; 40: 2244-2250.